American Orthopaedic Society for Sports Medicine (AOSSM) — 2026 Annual Meeting

Event dates: July 8–11, 2026
Venue: Seattle Convention Center / I-Arch in Seattle, Washington, USA
Event theme (spotlight): “OrthoBiologics and the Modern Athlete: Optimizing Evidence, Recovery, and Return to Play”

This annual meeting is positioned as one of the leading orthopaedic sports medicine conferences, bringing together specialists and researchers across sports medicine disciplines for education, clinical insights, and high-value networking. The program highlight emphasizes modern treatment pathways—particularly orthobiologics—and the meeting is designed to connect evidence, recovery science, and return-to-play decision-making with practical clinical application.

1) Who attends (BUYERS / ATTENDEES)

While the meeting includes a broad professional audience, the “buyer” opportunity here is strongest when we think in terms of organizations that influence purchase decisions related to clinical education, treatment pathways, devices, biologics, surgical tools, and practice adoption. In most years, the attendee mix commonly centers on physician and clinician stakeholders, but the most commercially relevant buyers are often the decision influencers surrounding them—medical directors, research leads, clinical education leaders, innovation/product adoption teams, and leadership within sports medicine ecosystems.

Primary attendee groups (attendees who shape needs):

• Orthopaedic sports medicine physicians (the core clinical audience; high credibility and high relevance to biologics, surgical technique, and rehabilitation outcomes)
• Orthopaedic surgeons and fellowship-trained sports medicine specialists
• Sports medicine researchers (translational research and evidence development that informs adoption)
• Allied health professionals closely tied to recovery and return to play (often involved in evidence translation and clinical pathway design)
• Industry exhibitors and sponsors (organizations that market products and services tied to the meeting’s clinical focus)

Buyer categories to target inside exhibitor and sponsor ecosystems:

• Product and clinical marketing leadership for orthobiologics, sports medicine portfolios, orthopaedic surgical products, and rehabilitation-related solutions
• Clinical education leaders (training, KOL enablement, continuing education strategy, and evidence dissemination)
• Medical affairs / scientific affairs leadership (evidence alignment, scientific communication, investigator support)
• Business development and partnerships leaders (health systems, distributor networks, and physician group collaborations)

For attendee list research, the best buyer fit typically comes from roles that either (a) hold budgets for education and clinical programs, (b) influence formulary or pathway adoption through evidence and education, or (c) coordinate industry-sponsored clinical engagement.

2) Where the show is happening + attendee geographic origin

Location: Seattle Convention Center / I-Arch, Seattle, Washington, USA
Country: United States

Likely geographic origin of attendees: Because this is a major orthopaedic sports medicine meeting, the audience usually draws professionals from across the United States and is also recognized internationally. The clinical specialty nature and reputation of the meeting typically lead to cross-border participation, with international physicians, researchers, and industry participants attending for education and networking.

Best geographic targeting approach we recommend:

• Primary: United States national coverage (especially from major medical hubs and sports medicine centers)
• Secondary: International coverage (Canada and other countries with active sports medicine research communities)
• Local amplification: Washington state + nearby regions for higher likelihood of attendance and on-site engagement

This event is ideal for research and outreach that requires clinically credible audiences. For buyer fit, we prioritize records that reflect clinician influence plus industry-facing roles that can convert education interest into product adoption, partnerships, or evidence-driven programs.

3) Audience reach (Local / National / Global)

Reach level: National with global relevance.

The meeting is presented as a top-tier orthopaedic sports medicine event that convenes colleagues “across disciplines and around the world.” Practically, this means the attendee pool is national-first (given the scale and specialized nature of the community) while still attracting international stakeholders through the global reputation of orthopaedic sports medicine research and clinical practice.

• Local: Seattle-area participation exists, but it is not the defining reach driver.
• National: Strong U.S. participation across orthopedic and sports medicine organizations.
• Global: International recognition creates a consistent international component, especially among researchers and industry participants.

4) Sample buyer company names (BUYERS ONLY) + Websites

Below are sample buyer-style targets that we would typically validate for fit based on the meeting’s orthopaedics, sports medicine, and orthobiologics focus. Because we must align the buyer selection with your exact product needs, these samples are a starting set; we would refine them once we review your website and product category.

Important note: Some sample rows above are conditional because buyer fit depends entirely on what your client sells (device? biologics? rehab technology? education platform? distribution?). Once we review your website, we replace conditional or “portfolio-adjacent” options with exact-fit buyers.

5) Job profiles, industries & event type

Best job profiles to target (buyer and decision-influencer roles):

• Director / Head of Medical Affairs (evidence alignment, clinical support, scientific communication)
• Clinical Education Lead (training strategy, workshops, KOL enablement)
• Product Manager / Product Marketing Director (sports medicine, orthopaedics, orthobiologics, regenerative medicine)
• Scientific Affairs Director (research messaging, clinical evidence planning)
• Business Development Manager (hospital systems partnerships, distributor strategy)
• Market Access / Strategy Lead (coverage narratives and adoption readiness)
• Regional Sales Director / Territory Manager (conference-driven conversion)
• Chief Medical Officer / Clinical Operations Director (clinic buyers for regenerative/admin workflows)
• Director of Sports Medicine Programs (institutional clinical program leadership)
• Research Partnerships Manager (institution-level collaborations)

Event type:

• Medical / clinical conference
• Specialty education and research meeting for orthopaedic sports medicine
• Exhibitor hall engagement with dedicated exhibit time and networking opportunities

Industries we map for this event (using the available industry taxonomy):

• Hospital & Health Care
• Medical Devices
• Medical Practice
• Pharmaceuticals (only if your offering includes biologics/pharma adjacency)
• Research (research-focused buyers)
• Events Services (only if your client provides event/education enablement services)

6) Estimated attendance (expected total footfall)

The official website content provided does not include a specific attendance number for 2026. To avoid guessing, we return this as unconfirmed based on the primary source text.

Estimated attendance: Not stated in the provided official page text.

In practice, for planning attendee-list volume and buyer density, we recommend prioritizing the most conversion-ready roles (medical affairs, clinical education, product marketing, business development) rather than relying on total footfall alone—because clinical conferences can include many attendee types, and buyer-fit varies significantly by job function.

7) Key focus areas & buyer engagement

The meeting’s program spotlights OrthoBiologics and the Modern Athlete, emphasizing evidence, recovery, and return to play. That single theme strongly signals buyer interest in:

• Biologics and regenerative pathways (evidence and adoption readiness)
• Recovery optimization and functional outcomes
• Clinical decision-making and return-to-play protocols
• Education and dissemination of research insights
• Clinical education programs and KOL engagement
• Product and solution storytelling grounded in modern evidence

Buyer engagement angles we recommend for outreach:

• Evidence-to-adoption messaging: frame your offering around clinical evidence, outcomes, and use-case protocols
• Clinician enablement: highlight training, education support, and clinical communications
• Recovery and performance language: align copy and targeting with “return to play” outcomes
• Target role clarity: outreach should be segmented by medical affairs vs product marketing vs clinical education vs business development

Additionally, the exhibitor approach on the official page mentions improved exhibit hours and dedicated breaks without competing educational sessions—this typically increases direct interaction quality between exhibitors and attendees.

8) Client-product fit: buyers who purchase attendee lists and the best buyer selection

We can absolutely refine the “best buyers” for AOSSM 2026 based on your client’s exact offering. However, we need the client’s website (and ideally the product category) to make the best-matching selections.

Please share the client website URL. We will then:

• review what the client sells (device/biologics/education/software/services/clinic workflow, etc.)
• map to the most relevant exhibitor and institutional buyer segments for sports medicine and orthobiologics
• recommend the highest-fit buyer company list (and the correct job titles to target)
• remove any buyers that are only “adjacent” but not a strong category match

What we’ll use as a fit trigger once we review the site: product modality, clinical setting (hospital, clinic, research institute), evidence requirements, whether the buyer is medical affairs vs marketing vs clinical education vs partnerships, and whether the product is orthobiologics/regen-forward or a different sports medicine category.

Until we receive the website, the “sample buyer list” above remains a directional set only—not the final optimized shortlist.

9) Final recommendation: is this event good for attendee-list research, and who should be prioritized?

Yes—this is a strong event for buyer-focused attendee-list research, especially for categories tied to orthopaedic sports medicine, modern recovery science, and orthobiologics. The meeting’s specialty positioning and the spotlight on recovery/return-to-play make it a high-intent environment where buyer relevance can be very strong when targeting is role-specific.

Highest priority buyer segments to collect (once your product is confirmed):

• Medical affairs / scientific affairs leadership (evidence and clinical engagement)
• Clinical education leadership (training, dissemination, and KOL programs)
• Product marketing / product management (sports medicine and orthobiologics portfolios)
• Business development / partnerships (institution conversion and distributor relationships)
• Specialty practice leadership if your client sells to clinics or care delivery organizations

Next step: Share your client website and we will return a tightened buyer list (company + best title targets) that matches the client requirements, plus a revised priority table and recommended industry filters based on your product category.